Delivery Order SPE2DB20D1100-SPE2DB24FD5M1

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,433.18 firm fixed-price delivery order is for the supply of Acetazolamide ER 500 mg capsules, with a performance period ending on May 7, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,954.56 and a period of performance through June 9, 2025. Amerisourcebergen Drug Corp is supplying a range of pharmaceutical products and medical supplies, including medications across various therapeutic areas such as diabetes, neurology, pain management, and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,570.43 and a completion date of July 1, 2025. The contract is not set aside and involves the delivery of a range of pharmaceutical products and medical supplies, including medications across various therapeutic areas such as diabetes, neurology, pain management,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, has a ceiling value of $29,247.48 and a completion date of June 17, 2025. AmerisourceBergen Drug Corp is providing a range of pharmaceutical products and medical supplies, including medications across various therapeutic areas such as diabetes,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has a ceiling value of $1,842.40 and a period of performance ending on May 30, 2025. The contract is not set-aside and is for the delivery of various pharmaceutical and medical products, including medications...
This is a firm fixed-price delivery order contract awarded by the Medical Supply Chain, a division of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,565.60 and a performance period through May 2025. It is a non-set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,254.32 and an ultimate completion date of June 11, 2025. Amerisourcebergen Drug Corp, a for-profit organization, is providing a variety of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,396.92 and a period of performance through July 1, 2025. Amerisourcebergen has been contracted to provide a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,942.90 and a period of performance through May 30, 2025. AmerisourceBergen is supplying a range of pharmaceutical products and medical supplies to support military healthcare programs, including medications across multiple therapeutic areas such as diabetes,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,920.32 and a period of performance through April 2025. Amerisourcebergen will deliver a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics....
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD5M1
    Delivery Order

This is a Firm Fixed Price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of acetazolamide ER 500 mg capsules. The contract has a ceiling value of $2,138.53 and runs through August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of the DLA Troop Support Medical Indefinite Delivery Contract, which has a total potential value of up to $999,999,999 through December 2025. This contract supports the provision of a wide range of medical commodities, including prescription medications, to military treatment facilities and other federal healthcare programs. The contract is not designated as a set-aside.

Generated 11/28/24, 9:28 AM